Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells

Lon is a nuclear‐encoded, mitochondrial protease that assists protein folding, degrades oxidized/damaged proteins, and participates in maintaining mtDNA levels. Here we show that Lon is up‐regulated in several human cancers and that its silencing in RKO colon cancer cells causes profound alterations of mitochondrial proteome and function, and cell death. We silenced Lon in RKO cells by constitutive or inducible expression of Lon shRNA. Lon‐silenced cells displayed altered levels of 39 mitochondrial proteins (26% related to stress response, 14.8% to ribosome assembly, 12.7% to oxidative phosphorylation, 8.5% to Krebs cycle, 6.3% to β‐oxidation, and 14.7% to crista integrity, ketone body catabolism, and mtDNA maintenance), low levels of mtDNA transcripts, and reduced levels of oxidative phosphorylation complexes (with >90% reduction of complex I). Oxygen consumption rate decreased 7.5‐fold in basal conditions, and ATP synthesis dropped from 0.25 ± 0.04 to 0.03 ± 0.001 nmol/mg proteins, in the presence of 2‐deoxy‐D‐glucose. Hydrogen peroxide and mitochondrial superoxide anion levels increased by 3‐ and 1.3‐fold, respectively. Mitochondria appeared fragmented, heterogeneous in size and shape, with dilated cristae, vacuoles, and electrondense inclusions. The triterpenoid 2‐cyano‐3,12‐dioxooleana‐1,9,‐dien‐28‐oic acid, a Lon inhibitor, partially mimics Lon silencing. In summary, Lon is essential for maintaining mitochondrial shape and function, and for survival of RKO cells.—Gibellini, L., Pinti, M., Boraldi, F., Giorgio, V., Bernardi, P., Bartolomeo, R., Nasi, M., De Biasi, S., Missiroli, S., Carnevale, G., Losi, L., Tesei, A., Pinton, P., Quaglino, D., Cossarizza, A., Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. FASEB J. 28, 5122–5135 (2014). www.fasebj.org

[1]  A. Schimmer,et al.  Mitochondrial matrix proteases as novel therapeutic targets in malignancy , 2014, Oncogene.

[2]  Jianxin Lu,et al.  Down-Regulating Overexpressed Human Lon in Cervical Cancer Suppresses Cell Proliferation and Bioenergetics , 2013, PloS one.

[3]  M. Kao,et al.  Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species , 2013, Cell Death and Disease.

[4]  W. Kuo,et al.  Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells , 2013, Cell Death and Disease.

[5]  Bin Xu,et al.  Colorectal Cancer Cells Refractory to Anti-VEGF Treatment Are Vulnerable to Glycolytic Blockade due to Persistent Impairment of Mitochondria , 2013, Molecular Cancer Therapeutics.

[6]  D. Temiakov,et al.  Phosphorylation of human TFAM in mitochondria impairs DNA binding and promotes degradation by the AAA+ Lon protease. , 2013, Molecular cell.

[7]  M. Andreeff,et al.  The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. , 2012, Blood.

[8]  V. Giorgio,et al.  The effects of idebenone on mitochondrial bioenergetics , 2012, Biochimica et biophysica acta.

[9]  B. Stockwell,et al.  Inhibitors of protein disulfide isomerase suppress apoptosis induced by misfolded proteins , 2010, Nature chemical biology.

[10]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[11]  S. Franken,et al.  The role of protein quality control in mitochondrial protein homeostasis under oxidative stress , 2010, Proteomics.

[12]  E. Morselli,et al.  Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease , 2010, AIDS.

[13]  P. Roepstorff,et al.  Identification of Novel Oxidized Protein Substrates and Physiological Partners of the Mitochondrial ATP-dependent Lon-like Protease Pim1* , 2010, The Journal of Biological Chemistry.

[14]  M. Bertagnolli,et al.  Molecular origins of cancer: Molecular basis of colorectal cancer. , 2009, The New England journal of medicine.

[15]  Andrea Cossarizza,et al.  Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry , 2009, Nature Protocols.

[16]  A. Tanca,et al.  Generation of high‐quality protein extracts from formalin‐fixed, paraffin‐embedded tissues , 2009, Proteomics.

[17]  A. Harris,et al.  Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis , 2009, British Journal of Cancer.

[18]  K. Davies,et al.  Mitochondrial Lon protease is a human stress protein. , 2009, Free radical biology & medicine.

[19]  G. Ingravallo,et al.  p38α blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1α- to FoxO-dependent transcription , 2009, Cell Death and Differentiation.

[20]  B. Friguet,et al.  Mitochondrial protein quality control: Implications in ageing , 2008, Biotechnology journal.

[21]  Shih-Hsiung Wu,et al.  Thermodynamic characterization of specific interactions between the human Lon protease and G-quartet DNA , 2007, Nucleic acids research.

[22]  Elisa Nemes,et al.  Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry , 2007, Nature Protocols.

[23]  M. Madesh,et al.  Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy , 2007, Nature Protocols.

[24]  C. Newlon,et al.  Roles for the Human ATP-dependent Lon Protease in Mitochondrial DNA Maintenance* , 2007, Journal of Biological Chemistry.

[25]  A. Mogk,et al.  Proteomic Analysis of Mitochondrial Protein Turnover: Identification of Novel Substrate Proteins of the Matrix Protease Pim1 , 2006, Molecular and Cellular Biology.

[26]  B. Guiard,et al.  Structural properties of substrate proteins determine their proteolysis by the mitochondrial AAA+ protease Pim1 , 2005, Biological chemistry.

[27]  M. Tohyama,et al.  Transmission of cell stress from endoplasmic reticulum to mitochondria , 2002, The Journal of cell biology.

[28]  C. Mussini,et al.  Increased Mitochondrial Dna Content in Peripheral Blood Lymphocytes from HIV-Infected Patients with Lipodystrophy , 2002, Antiviral therapy.

[29]  G. Schatz,et al.  Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. , 1994, Science.

[30]  F. Sherman,et al.  PIM1 encodes a mitochondrial ATP-dependent protease that is required for mitochondrial function in the yeast Saccharomyces cerevisiae. , 1994, The Journal of biological chemistry.

[31]  H. Osiewacz,et al.  Mitochondrial protein quality control systems in aging and disease. , 2010, Advances in experimental medicine and biology.